Up Next

ki-logo-white
Market-Based Solutions to Vital Economic Issues

SEARCH

ki-logo-white
Market-Based Solutions to Vital Economic Issues

vaccine

SHOW ME:

AI. CRISPR. mRNA. Key components of the rapidly expanding alphabet soup of technologies driving a boom in healthcare innovation. In this Kenan Insight, we explore why the 2021 Trends in Entrepreneurship Report names emerging technology in the healthcare industry as a key trend, along with some of the challenges that come with fast-moving technological advancements.

The current narrative around the U.S. labor market is a mixed bag, with unemployment numbers well above pre-pandemic rates while many companies struggle to fill jobs. In this Kenan Insight Q&A, three experts weigh in on the critical issues behind this dichotomy.

Apr 14, 2021

The Global-K Recovery

The 2020 COVID-fueled economic downturn generated what has been referred to as a "K-shaped" recession, with both big losers (such as restaurants and the hospitality sector) and big winners (such as high tech and online retail). In this Kenan Insight, we explore how a nascent K-shaped recovery will likely affect U.S. businesses and households.

How have AstraZeneca's recent missteps in reporting COVID-19 vaccine clinical trial results affected the public's trust, and what's next on the road to FDA approval? Hear from Emmes Chief Business Officer Lynn Lewis.

The factors that determine our health go far beyond what happens in the doctor’s office. In this Kenan Insight, we explore how the physical well-being of many Americans has been placed in jeopardy by upstream social and economic factors such as racism, food and job insecurity, and a lack of community and social support systems.

The arrival of two approved COVID-19 vaccines provides a clear path to the end of the pandemic that held most of 2020 hostage. But a recent resurgence of the virus and skyrocketing rates of infection indicate that a full return to normalcy—including the pre-pandemic work environment— is still months in the future. In this Kenan Insight, we examine the relevant factors that will determine when and how we go back to the office.

As a second wave of COVID-19 cases makes its way around the world, the danger to the U.S. economy is clear. In this Kenan Insight, we examine the potentially damaging effects of the ongoing pandemic on an already battered workforce, and make the case for why Congress must act quickly to ensure economic stability.

LabCorp Executive Vice President & President of Diagnostics Brian Caveney joined UNC Kenan-Flagler Business School Associate Dean of MBA Programs & Faculty Director of the Center for the Business of Health Brad Staats on Friday, Nov. 13 for an exclusive conversation as part of the 10th Annual Business of Healthcare Conference. This virtual fireside chat was part of the Dean’s Speaker Series, hosted by Kenan-Flagler Business School Dean Doug Shackelford.

Join the Center for the Business of Health virtually as they discuss the complexity of the healthcare ecosystem and how innovation and interconnectivity are necessary to build a more robust and flexible system.

Please join us for an exclusive conversation with LabCorp Executive Vice President & President of Diagnostics Brian Caveney on Friday, Nov. 13. This virtual fireside chat is part of the Dean’s Speaker Series, hosted by Kenan-Flagler Business School Dean Doug Shackelford. The discussion will be led by Brad Staats, Associate Dean of MBA Programs, Professor of Operations, Sarah Graham Kenan Scholar & Faculty Director of the Center for the Business of Health.

The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.

The global COVID-19 pandemic has been a recurring theme throughout the 2020 U.S. elections, and its health and economic consequences will be felt far beyond November 3. In this Kenan Insight, we look at both the challenges and potential opportunities the pandemic has created for accelerating innovations in healthcare delivery and pharmaceutical development.